Dexcom Stock News

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference: Jereme Sylvain, Executive Vi

These businesses have been very efficient in generating profits Related Stocks: ZTS , DXCM , ZBRA , CNHI ,

When a company's return on equity (ROE) ratio is better than most of its competitors, it generally indicates that the company has been very efficient in generating profits. Thus, investors may want to

DexCom Inc. (NASDAQ:DXCM) shares, rose in value on Friday, 11/26/21, with the stock price down by -1.11% to the previous days close as strong demand from buyers drove the stock to $591.96. Actively observing the price movement in the last trading, the stock closed the session at $598.58, falling within a range of $589.45 and Is DexCom Inc. (NASDAQ: DXCM) A Good Pick For New Investors Now? Read More »

After a strong reaction to its last earnings report, we locked in gains because of these rules.

HNP Capital LLC raised its stake in DexCom, Inc. (NASDAQ:DXCM) by 3.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,895 shares of the medical device companys stock after acquiring an additional 122 shares during the period. HNP Capital LLCs holdings in DexCom []

Related Stocks: DXCM ,

DexCom, Inc. (NASDAQ:DXCM) insider Steven Robert Pacelli sold 250 shares of the firms stock in a transaction dated Tuesday, November 23rd. The stock was sold at an average price of $612.26, for a total transaction of $153,065.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through []

DexCom, Inc. (NASDAQ:DXCM) EVP Sadie Stern sold 856 shares of the stock in a transaction dated Monday, November 22nd. The shares were sold at an average price of $638.65, for a total value of $546,684.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. []

IFM Investors Pty Ltd raised its position in DexCom, Inc. (NASDAQ:DXCM) by 0.7% during the third quarter, Holdings Channel.com reports. The firm owned 12,697 shares of the medical device companys stock after buying an additional 93 shares during the period. IFM Investors Pty Ltds holdings in DexCom were worth $6,943,000 at the end of the []

In our continuing quest to spread facts and not bullshit we thought today we would prove just how childish corporations can be. As much as wed like to think there are adults at the table when it comes to this battle between Abbott and Dexcom, The post Pennies + Nickels = Billions appeared first on Diabetic Investor .

Shares of DexCom, Inc. (NASDAQ:DXCM) have received a consensus rating of Buy from the eighteen research firms that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year price objective among brokers []

Harbor Investment Advisory LLC cut its holdings in DexCom, Inc. (NASDAQ:DXCM) by 33.2% in the third quarter, HoldingsChannel reports. The firm owned 771 shares of the medical device companys stock after selling 383 shares during the quarter. Harbor Investment Advisory LLCs holdings in DexCom were worth $422,000 at the end of the most recent reporting []

New England Research & Management Inc. reduced its stake in shares of DexCom, Inc. (NASDAQ:DXCM) by 63.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 460 shares of the medical device companys stock after selling 815 shares during the period. []